Rani Therapeutics Holdings, Inc. (RANI) — Institutional Holders & Catalysts | BiotechEdge

BiotechEdgeBeta

Catalysts Convergence Compare Insiders Runway Squeeze Signals Research

Sign In Start Free Trial

← Back to home

Rani Therapeutics Holdings, Inc.

RANI

Held by 1 specialist biotech fund

High short interest · No specialist buying

B

BiotechEdge

Catalysts Convergence Insiders Cash Runway Research Pricing

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback Terms Privacy Disclaimer

Fund Holdings

RA Capital ManagementNew

Short Interest

High short interest

Short Shares

10.56M

Change

-8.8%

Days to Cover

13.3

% of Float

11.2%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13GRA Capital Management9.9%Oct 30, 2025

Position Details

RA Capital ManagementNEWFeb 17, 2026

Shares: 8,500,000Value: $11.5M

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

VOR1 fund BCRX1 fund BLTE1 fund CAPR1 fund CCCC1 fund CTNM1 fund DSGN1 fund CLYM1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: